4th International Conference on

Innovations and Advances in Cancer Research and Treatment

October 08–09, 2026 | Tokyo, Japan

ANA Crowne Plaza Narita
Address: 68 Horinouchi, Narita, Chiba 286-0107, Japan
Email: cancer@scitechconference.com
Phone: +44 2045874848
WhatsApp: +44 7429481517

Liquid Biopsy

Liquid Biopsy

Liquid Biopsy has emerged as a minimally invasive diagnostic approach that enables real-time monitoring of cancer progression and treatment response through the analysis of circulating tumor components. This session will explore recent developments in circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and other blood-based biomarkers used in cancer detection and management. Experts will discuss the clinical utility of liquid biopsy in early cancer diagnosis, therapy selection, disease monitoring, and recurrence detection. The session will also address technological innovations, analytical challenges, standardization efforts, and the future integration of liquid biopsy into routine oncology practice to support personalized and precision cancer care.

Sub tracks:

  • Circulating tumor DNA and biomarkers
  • Early cancer detection techniques
  • Monitoring treatment response and relapse
  • Non-invasive cancer diagnostics
  • Technological innovations in liquid biopsy
  • Clinical applications in precision oncology

Related Sessions